Development and evaluation of isradipine via rutin-loaded coated solid–lipid nanoparticles

The objective was to develop a stable and non-compliance coated solid–lipid nanoparticles (coated SLN) using polymer (Eudragit L100) and lipoid (glycerol monostearate: soya lecithin) for partial dose reduction of isradipine [ISR; 2.5 mg by combination of bioenhancing agent (rutin; Ru) in equivalent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vikash, Chaudhary, Hema, Kamboj, Anjoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376350/
https://www.ncbi.nlm.nih.gov/pubmed/30792921
http://dx.doi.org/10.1556/1646.10.2018.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376350/
https://www.ncbi.nlm.nih.gov/pubmed/30792921
http://dx.doi.org/10.1556/1646.10.2018.45

Ejemplares similares